US excipients demand will grow 4.5 percent annually through 2011. Gelatin will remain the leading compound over the intermediate term, but cellulose derivatives will eventually become the top-selling group. Other excipients expected to fare well include calcium phosphate, povidone, pregelatinized starch, petrolatum, polysorbate and natural gums. This study analyzes the $2.3 billion excipients industry. It presents historical demand data for the years 1996, 2001 and 2006, and forecasts for 2011 and 2016 by product (e.g., gelatin, cellulose derivatives, synthetic polymers, minerals, starch compounds, sugars, polyols, sterile and purified waters, surfactants); and application (e.g., fillers/diluents, capsules, binders, drug delivery agents, suspension/viscosity agents, coatings). The study also considers market environment factors, details industry structure and market share, and profiles 45 leading players including Dow Excipients, BASF Pharma Solutions, Aqualon, Cargill Pharmaceutical Excipients, Colorcon, and National Starch and Chemical.